
A proposed securities class action alleges Microvast overstated its ability to meet margin goals and complete the Huzhou Phase 3.2 expansion by the end of 2025 before the market learned more details.
Microvast Holdings, Inc. investors who purchased securities between April 1, 2025 and March 16, 2026 have until September 21, 2026 to seek appointment as lead plaintiff in a proposed securities class action. The lawsuit, announced by Rosen Law Firm, alleges Microvast and related defendants made materially false and misleading statements or omitted material information during the class period. The complaint claims the company overstated its ability to reach margin targets because of inventory management issues and delays in commercial vehicle rollouts by customers, and also overstated its ability to complete the Huzhou Phase 3.2 expansion by the end of 2025. The filing contends those statements were materially false and misleading at the time they were made and that investors suffered damages when the underlying details entered the market. Rosen Law Firm said a class action has already been filed and that investors who do not seek lead plaintiff status may still be eligible to share in any potential recovery if a class is later certified.